Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | GNG2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BARHL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZCCHC3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CECR2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TP53INP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CSE1L | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TRIM24 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HMGN4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |